Citius Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTOR and other ETFs, options, and stocks.About CTOR
Citius Oncology, Inc. is a biopharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma.
CTOR Key Statistics
Stock Snapshot
The current Citius Oncology(CTOR) stock price is $0.57, with a market capitalization of 53.4M. The stock trades at a price-to-earnings (P/E) ratio of -1.25.
On 2026-11-03, Citius Oncology(CTOR) stock moved within a range of $0.57 to $0.64. With shares now at $0.57, the stock is trading +0.4% above its intraday low and -11.4% below the session's peak.
Trading volume for Citius Oncology(CTOR) stock has reached 77.68K, versus its average volume of 221.18K.
The stock's 52-week range extends from a low of $0.49 to a high of $1.83.
The stock's 52-week range extends from a low of $0.49 to a high of $1.83.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.